Aminotriazolopyridines as kinase inhibitors
Compounds having formula (I) (IX), and enantiomers, and diastereomers, stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein: (I), (II), (III), (IV), (V), (VI), (VII), (VIII), (IX).
Bristol-Myers Squibb Company
A C A A C A
A61P C07F A61P A61P C07D A61P
inventional inventional inventional inventional inventional inventional
John E. Amy C. Scott Hunter William J. Jie Carolyn Diane Michael E. Sing-Yuen Murugaiah Steven H. Guanglin Junqing Jianliang
Macor Hart Watterson Pitts Chen Dzierba Mertzman Sit Andappan Murugaiah Subbaiah Spergel Luo Guo Shi